Spectrum Pharmaceuticals: Funding, Investors & Team (Sep 2026)
Spectrum Pharmaceuticals is a commercial-stage biotechnology company with fully integrated commercial and drug development operations, and a focus in oncology and hematology.
Spectrum Pharmaceuticals has raised $50.0M across 2 funding rounds on record, the most recent a Post-IPO Debt of $30.0M announced in Sep 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Spectrum Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2022.
Spectrum Pharmaceuticals Funding Rounds
Spectrum Pharmaceuticals raised $20.0M in a Post-IPO Equity announced in Jan 2022.
8 months later, a Post-IPO Debt of $30.0M was announced in Sep 2022.
Spectrum Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Spectrum Pharmaceuticals Funding Compared to Other Biotechnology Startups
Spectrum Pharmaceuticals' latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Spectrum Pharmaceuticals in Biotechnology and Henderson
Companies Similar to Spectrum Pharmaceuticals
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Spectrum Pharmaceuticals Funding FAQs
What does Spectrum Pharmaceuticals do?
Spectrum Pharmaceuticals is a commercial-stage biotechnology company with fully integrated commercial and drug development operations, and a focus in oncology and hematology.
How much funding has Spectrum Pharmaceuticals raised?
Spectrum Pharmaceuticals has raised $50.0M across 2 rounds on record. The most recent is a Post-IPO Debt of $30.0M announced in Sep 2022.
When did Spectrum Pharmaceuticals last raise funding?
Spectrum Pharmaceuticals' most recent funding round on record is a Post-IPO Debt of $30.0M, announced in Sep 2022.
Who is the CEO of Spectrum Pharmaceuticals?
Rajesh Shrotriya is listed as CEO at Spectrum Pharmaceuticals.
Where is Spectrum Pharmaceuticals headquartered?
Spectrum Pharmaceuticals is based in Henderson, Nevada, United States.
How many employees does Spectrum Pharmaceuticals have?
Spectrum Pharmaceuticals is in the 251-500 employee band.
How does Spectrum Pharmaceuticals' funding compare to other Biotechnology startups?
Spectrum Pharmaceuticals' latest round of $30.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Spectrum Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spectrum Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.